162 related articles for article (PubMed ID: 36295489)
21. Development of an integrated predictive model for postoperative glioma-related epilepsy using gene-signature and clinical data.
Li L; Zhang C; Wang Z; Wang Y; Guo Y; Qi C; You G; Zhang Z; Fan X; Jiang T
BMC Cancer; 2023 Jan; 23(1):42. PubMed ID: 36631762
[TBL] [Abstract][Full Text] [Related]
22. Novel Immune-Related Gene Signature for Risk Stratification and Prognosis of Survival in Lower-Grade Glioma.
Zhang M; Wang X; Chen X; Zhang Q; Hong J
Front Genet; 2020; 11():363. PubMed ID: 32351547
[TBL] [Abstract][Full Text] [Related]
23. Prognostic Model and Nomogram Construction Based on a Novel Ferroptosis-Related Gene Signature in Lower-Grade Glioma.
Zhao J; Liu Z; Zheng X; Gao H; Li L
Front Genet; 2021; 12():753680. PubMed ID: 34819946
[No Abstract] [Full Text] [Related]
24. Plasma miRNAs in predicting radiosensitivity in non-small cell lung cancer.
Chen X; Xu Y; Liao X; Liao R; Zhang L; Niu K; Li T; Li D; Chen Z; Duan Y; Sun J
Tumour Biol; 2016 Sep; 37(9):11927-11936. PubMed ID: 27075472
[TBL] [Abstract][Full Text] [Related]
25. Development and Validation of a Radiosensitivity Prediction Model for Lower Grade Glioma Based on Spike-and-Slab Lasso.
Du Z; Cai S; Yan D; Li H; Zhang X; Yang W; Cao J; Yi N; Tang Z
Front Oncol; 2021; 11():701500. PubMed ID: 34395274
[TBL] [Abstract][Full Text] [Related]
26. A Novel lncRNA Panel Related to Ferroptosis, Tumor Progression, and Microenvironment is a Robust Prognostic Indicator for Glioma Patients.
He Y; Ye Y; Tian W; Qiu H
Front Cell Dev Biol; 2021; 9():788451. PubMed ID: 34950662
[No Abstract] [Full Text] [Related]
27. Combination of Radiosensitivity Gene Signature and PD-L1 Status Predicts Clinical Outcome of Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma: A Study Based on The Cancer Genome Atlas Dataset.
Dai D; Guo Y; Shui Y; Li J; Jiang B; Wei Q
Front Mol Biosci; 2021; 8():775562. PubMed ID: 34970597
[No Abstract] [Full Text] [Related]
28. Comprehensive profiling identifies a novel signature with robust predictive value and reveals the potential drug resistance mechanism in glioma.
Zeng F; Wang K; Liu X; Zhao Z
Cell Commun Signal; 2020 Jan; 18(1):2. PubMed ID: 31907037
[TBL] [Abstract][Full Text] [Related]
29. A Novel Signature Constructed by RNA-Binding Protein Coding Genes to Improve Overall Survival Prediction of Glioma Patients.
Tu Z; Shu L; Li J; Wu L; Tao C; Ye M; Zhu X; Huang K
Front Cell Dev Biol; 2020; 8():588368. PubMed ID: 33634092
[TBL] [Abstract][Full Text] [Related]
30. Clinical Biomarkers of Tumour Radiosensitivity and Predicting Benefit from Radiotherapy: A Systematic Review.
Bleaney CW; Abdelaal H; Reardon M; Anandadas C; Hoskin P; Choudhury A; Forker L
Cancers (Basel); 2024 May; 16(10):. PubMed ID: 38792019
[TBL] [Abstract][Full Text] [Related]
31. Prognosis prediction based on methionine metabolism genes signature in gliomas.
Zhou S; Zhao X; Zhang S; Tian X; Wang X; Mu Y; Li F; Zhao AZ; Zhao Z
BMC Med Genomics; 2023 Dec; 16(1):317. PubMed ID: 38057821
[TBL] [Abstract][Full Text] [Related]
32. Identification of robust diagnostic and prognostic gene signatures in different grades of gliomas: a retrospective study.
Liu J; Zhang H; Zhang J; Bing Z; Wang Y; Li Q; Yang K
PeerJ; 2021; 9():e11350. PubMed ID: 34026352
[TBL] [Abstract][Full Text] [Related]
33. Construction of a novel mRNA-signature prediction model for prognosis of bladder cancer based on a statistical analysis.
Li J; Cao J; Li P; Yao Z; Deng R; Ying L; Tian J
BMC Cancer; 2021 Jul; 21(1):858. PubMed ID: 34315402
[TBL] [Abstract][Full Text] [Related]
34. Gene signatures predict biochemical recurrence-free survival in primary prostate cancer patients after radical therapy.
Su Q; Liu Z; Chen C; Gao H; Zhu Y; Wang L; Pan M; Liu J; Yang X; Tian J
Cancer Med; 2021 Sep; 10(18):6492-6502. PubMed ID: 34453418
[TBL] [Abstract][Full Text] [Related]
35. RNA processing genes characterize RNA splicing and further stratify lower-grade glioma.
Chai RC; Li YM; Zhang KN; Chang YZ; Liu YQ; Zhao Z; Wang ZL; Chang YH; Li GZ; Wang KY; Wu F; Wang YZ
JCI Insight; 2019 Aug; 5(17):. PubMed ID: 31408440
[TBL] [Abstract][Full Text] [Related]
36. Identification of an IL-4-Related Gene Risk Signature for Malignancy, Prognosis and Immune Phenotype Prediction in Glioma.
Qi Y; Yang X; Ji C; Tang C; Xie L
Brain Sci; 2022 Jan; 12(2):. PubMed ID: 35203944
[TBL] [Abstract][Full Text] [Related]
37. Genotype prediction of ATRX mutation in lower-grade gliomas using an MRI radiomics signature.
Li Y; Liu X; Qian Z; Sun Z; Xu K; Wang K; Fan X; Zhang Z; Li S; Wang Y; Jiang T
Eur Radiol; 2018 Jul; 28(7):2960-2968. PubMed ID: 29404769
[TBL] [Abstract][Full Text] [Related]
38. An Immune-Related Signature for Predicting the Prognosis of Lower-Grade Gliomas.
Zhang H; Li X; Li Y; Chen B; Zong Z; Shen L
Front Immunol; 2020; 11():603341. PubMed ID: 33363544
[TBL] [Abstract][Full Text] [Related]
39. Integrating Intrinsic Radiosensitivity and Immune Status for Predicting Benefits of Radiotherapy in Head and Neck Squamous Cell Carcinoma.
Sun C; Zhang M; Qiao Q; Wang Y
Med Sci Monit; 2021 Oct; 27():e932126. PubMed ID: 34670999
[TBL] [Abstract][Full Text] [Related]
40. Identification and validation of a three-gene signature as a candidate prognostic biomarker for lower grade glioma.
Xiao K; Liu Q; Peng G; Su J; Qin CY; Wang XY
PeerJ; 2020; 8():e8312. PubMed ID: 31921517
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
